Journals / Marmara Medical Journal / 2026 / Volume: 24 Issue: 1

-

Klorokin ve Hidroksiklorokin Makülopatili İki Olgu

Pages
—
Publication Date
2015-04-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

-

Özet

İki antimalarial ilaç kullanımına bağlı retinopati olgusu sunduk ve antimalarial tedavisinde tarama yöntemlerini değerlendirdik. Retina bölümümüzde takip edilen iki olgunun klinik kayıtları, fundus fotoğrafları, görme alanı, flöresan anjiografileri incelendi. İlk olguda testler yapılmış olduğu halde sonuçlarının yanlış yorumlanması, ikinci olguda ise hastaya tarama testlerinin öneminin yeterince anlatılmamış olması sebep olarak görüldü. Anahtar Kelimeler: Klorokin, Hidroksiklorokin, Retinal toksisite

🔖

Cite This Article

Akman, F., Çerman, E., Yenice, Ö., Kazokoğlu, H. (2015). -. Marmara Medical Journal, Volume: 24 Issue: 1. https://ajindex.com/articles/1286986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Marmor FM. New American Academy of Ophtalmology recommendations on screening for hydroxychloroquine retinopathy. Arthritis Rheum 2003 Jun;48(6):1764. doi: 10.1002/art.10980
  2. Browning DJ. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol. 2002;133: 649- 656. doi: 10.1016/S0002-9394(02)01392-2
  3. Easterbrook M. Screening for antimalarial toxicity: current concepts. Can J Ophtalmol. 2002; 6:325- 328.
  4. Tehrani R, Ostrowski RA, Hariman R, Jay WM. Ocular toxicity of hydroxychloroquine. Semin Ophtalmol. 2008; 23:201- 209. doi: 10.1080/08820530802049962
  5. Rigaudière F, Ingster-Moati I, Hache JC, Leid J, Verdet R, Haymann P, Rigolet MH, Zanlonghi X, Defoort S, Le Gargasson JF: Updated ophtalmological screening and follow up management for long term antimalarial treatment. J Fr Ophtalmol 2004; 27:191- 199.
  6. Rüther K, Foerster J, Berndt S, et al. Chloroquine/hydroxychloroquine:variability of retinotoxic cumulative doses. Ophthalmologe 2007;104:875-879. doi: 10.1007/s00347-007- 1560-7
  7. Pluta JP, Rühter K. Retinal damage by (hydroxyl)chloroquine intake:published evidence for an efficient ophthalmological follow-up. Klin Monbl Augenheilkd 2009;226:891-896. Epub 2009 Nov. 13. doi 10.1055/s-0028-1109881
  8. Blyth C, Lane C: Hydroxychloroquine retinopathy:is screening necessary? BMJ. 1998; 316:716– 717
  9. Gilbert ME, Savino PJ: Missing the bull’s eye. Surv Ophtalmol 2007; 52:440- 442.
  10. Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG: High speed ultra high resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophtalmol 2007; 125: 775- 780.
  11. Razeghinejad MR, Torkaman F, Amini H: Blue yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy. Med Hypotheses 2005; 65:629- 630. doi: 10.1016/j.mehy.2005.04.005
  12. Gündüz K, Okka M, Zengin N, Okudan S, Özbayrak N,Acaroğlu Ş. Klorokin tedavisinde retina toksisitesinin araştırılması. T Klin Oftalmoloji 1995; 4: 47-51.
  13. Köse S, Akkın C, Ya_cı A, Ate_ H,Haznedaro_lu G. Klorokin retinopatisinin saptanması ve izlenmesinde kullanılan yöntemlerin etkinliği. MN Oftalmoloji 1993; 2: 299-301.
  14. Herman K, Leys A,Spileers W: Hydroxychloroquine retinal toxicity: two case reports and safety guidelines. Bull Soc Belge Ophtalmol 2002; 284: 21- 29.
  15. Tehrani R, Ostrowski RA, Hariman R, Jay WM. Ocular toxicity of hydroxychloroquine. Semin Ophtalmol. 2008; 23:201- 209. doi: 10.1080/08820530802049962
  16. Blyth C, Lane C: Hydroxychloroquine retinopathy:is screening necessary? BMJ. 1998; 316:716– 717
  17. Gilbert ME, Savino PJ: Missing the bull’s eye. Surv Ophtalmol 2007; 52:440- 442.
  18. Razeghinejad MR, Torkaman F, Amini H: Blue yellow perimetry can be an early detector of hydroxychloroquine and chloroquine retinopathy. Med Hypotheses 2005; 65:629- 630. doi: 10.1016/j.mehy.2005.04.005